NASDAQ:SIEN Sientra (SIEN) Stock Price, News & Analysis → Claim Your FREE 'AI Income Playbook' Now! (From The Oxford Club) (Ad) Free SIEN Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Today's Range N/A50-Day Range$0.17▼$0.6852-Week Range N/AVolume3.44 million shsAverage Volume4.15 million shsMarket Capitalization$2.08 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisAnalyst ForecastsEarningsHeadlinesInsider TradesOwnershipShort InterestTrendsStock AnalysisAnalyst ForecastsEarningsHeadlinesInsider TradesOwnershipShort InterestTrends Get Sientra alerts: Email Address Ad Porter & CompanyThe attacks will come for me after releasing this…America’s “Internal Enemies” Exposed New documentary exposes a hidden election plan in Washington D.C. that, if successful, could be more financially and culturally devastating than the dot-com blowup of 2000, the 2008 financial crisis, or the COVID crash.Click here to see how you can protect yourself today. About Sientra Stock (NASDAQ:SIEN)Sientra, Inc., a medical aesthetics company, develops and sells medical aesthetics products in the United States and internationally. It offers silicone gel breast implants for use in breast augmentation and breast reconstruction procedures; breast tissue expanders; and scar management products under the Sientra Round, Sientra Teardrop, AlloX2, Dermaspan, Softspan, and BIOCORNEUM brand names. The company also provides fat transfer systems; body contouring products; facial and nasal implants; saline filled sizers. It serves to hospitals, surgery centers, plastic surgeons, dermatologists, and other specialties. The company was formerly known as Juliet Medical, Inc. and changed its name to Sientra, Inc. in April 2007. Sientra, Inc. was incorporated in 2003 and is headquartered in Irvine, California. On February 12, 2024, Sientra, Inc., along with its affiliates, filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware.Read More Ad Porter & CompanyThe attacks will come for me after releasing this…America’s “Internal Enemies” Exposed New documentary exposes a hidden election plan in Washington D.C. that, if successful, could be more financially and culturally devastating than the dot-com blowup of 2000, the 2008 financial crisis, or the COVID crash.Click here to see how you can protect yourself today. SIEN Stock News HeadlinesMay 15, 2024 | finance.yahoo.comGlobal Breast Implant Market Projected to Reach US$ 4.1 Billion by 2032May 9, 2024 | msn.comPace Industries in Grafton announces it will lay off 90 workers beginning in JuneApril 30, 2024 | msn.comNine Wisconsin companies, including CNH Industrial, announced layoffs in April. About 890 workers affected.April 22, 2024 | morningstar.comSientra Inc SIENQApril 18, 2024 | finance.yahoo.comNuance Medical Completes Acquisition of BIOCORNEUM Scar Treatment Brand, to Become a Part of the Biodermis PortfolioApril 11, 2024 | markets.businessinsider.comNasdaq (NDAQ) Initiated with a Buy at BarclaysApril 3, 2024 | finanznachrichten.deSientra, Inc.: Sientra Announces Completion and Winning Bidders of its Section 363 Sales AuctionApril 3, 2024 | finance.yahoo.comNuance Medical Agrees to Acquire BIOCORNEUM Scar Treatment BrandApril 2, 2024 | globenewswire.comSientra Announces Completion and Winning Bidders of its Section 363 Sales AuctionMarch 15, 2024 | finance.yahoo.comGlobal Gynecomastia Procedures Market Size To Exceed USD 1900 Million by 2033 | CAGR Of 8.05%March 7, 2024 | wsj.comFirm Retention Summary: SientraFebruary 17, 2024 | finance.yahoo.comSIEN Mar 2024 2.500 callFebruary 15, 2024 | finanznachrichten.deSientra, Inc.: Sientra to Pursue Strategic Sale of its Business Through Voluntary Chapter 11 ProcessFebruary 15, 2024 | msn.comPlastic surgery company goes bust, files Chapter 11 bankruptcyFebruary 15, 2024 | msn.comPlastic-surgery company goes bust, files Chapter 11 bankruptcyFebruary 14, 2024 | msn.comImplant Maker Sientra Cleared to Draw Deerfield Bankruptcy LoanFebruary 13, 2024 | marketwatch.comHealth Care Limits Losses Amid Defensive Bias -- Health Care RoundupFebruary 13, 2024 | wsj.comBreast-Implant Maker Sientra Files for BankruptcyFebruary 13, 2024 | benzinga.comNasdaq Down Over 2%; Marriott Earnings Top ViewsFebruary 13, 2024 | markets.businessinsider.comSientra Files For Bankruptcy; Stock Tanks 65%February 13, 2024 | msn.comBreast-Implant Maker Sientra Files Bankruptcy After Consumer PullbackFebruary 13, 2024 | benzinga.comDow Dips Over 300 Points; US Annual Inflation Slows to 3.1% In JanuaryFebruary 13, 2024 | msn.comSientra drops on filing of voluntary Chapter 11 BankruptcyFebruary 13, 2024 | wsj.comSurgical Aesthetics Company Sientra Files for BankruptcyFebruary 13, 2024 | finance.yahoo.comSientra to Pursue Strategic Sale of its Business Through Voluntary Chapter 11 ProcessSee More Headlines Receive SIEN Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Sientra and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings11/10/2021Today6/15/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Medical Devices Sub-IndustryN/A Current SymbolNASDAQ:SIEN CUSIPN/A CIK1551693 Webwww.sientra.com Phone(805) 562-3500Fax805-562-8401Employees304Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)($5.57) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-73,310,000.00 Net Margins-65.93% Pretax Margin-65.68% Return on EquityN/A Return on Assets-40.45% Debt Debt-to-Equity RatioN/A Current Ratio0.57 Quick Ratio0.31 Sales & Book Value Annual Sales$90.55 million Price / Sales0.00 Cash FlowN/A Price / Cash FlowN/A Book Value($0.04) per share Price / BookN/AMiscellaneous Outstanding Shares11,960,000Free Float11,775,000Market Cap$2.08 million OptionableOptionable Beta2.04 Investing Strategies To Help Grow Your Retirement IncomeNeed to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.Get This Free Report Key ExecutivesMr. Ronald Menezes (Age 61)President, CEO & Director Comp: $501.18kMr. Andrew C. Schmidt (Age 63)Senior VP, Treasurer & CFO Comp: $365.4kMr. Oliver Christian Bennett (Age 47)Senior VP, Chief Legal, Compliance, & Corporate Development Officer Comp: $363.37kMr. Keith J. Sullivan (Age 66)Director & Advisor to MiraDry Business Comp: $40kMs. Caroline F. Van Hove (Age 43)Executive Chair of Board of Directors Comp: $197.74kDr. Denise DajlesChief Technical OfficerMr. Mark S. Saxton (Age 59)Senior Vice President Sales Ms. Adelle WalkerSenior Vice President of Corporate Strategy & MarketingMr. Matt HostetlerChief People OfficerMore ExecutivesKey CompetitorsAinosNASDAQ:AIMDWBone BiologicsNASDAQ:BBLGWDIH Holding USNASDAQ:DHAIWEnvoy MedicalNASDAQ:COCHWHeart Test LaboratoriesNASDAQ:HSCSWView All Competitors SIEN Stock Analysis - Frequently Asked Questions Should I buy or sell Sientra stock right now? 1 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Sientra in the last twelve months. There are currently 1 hold rating for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" SIEN shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in SIEN, but not buy additional shares or sell existing shares. View SIEN analyst ratings or view top-rated stocks. How were Sientra's earnings last quarter? Sientra, Inc. (NASDAQ:SIEN) announced its quarterly earnings results on Wednesday, November, 10th. The medical instruments supplier reported ($0.80) EPS for the quarter, beating analysts' consensus estimates of ($2.60) by $1.80. The medical instruments supplier earned $19.62 million during the quarter, compared to the consensus estimate of $18.10 million. During the same quarter in the prior year, the company posted ($3.30) EPS. When did Sientra's stock split? Sientra shares reverse split before market open on Monday, January 23rd 2023. The 1-10 reverse split was announced on Monday, January 23rd 2023. The number of shares owned by shareholders was adjusted after the market closes on Monday, January 23rd 2023. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split. What other stocks do shareholders of Sientra own? Based on aggregate information from My MarketBeat watchlists, some companies that other Sientra investors own include Rigel Pharmaceuticals (RIGL), Matinas BioPharma (MTNB), Sorrento Therapeutics (SRNE), VBI Vaccines (VBIV), ADMA Biologics (ADMA), Miragen Therapeutics (MGEN), Corbus Pharmaceuticals (CRBP), Dynavax Technologies (DVAX), Micron Technology (MU) and Novavax (NVAX). This page (NASDAQ:SIEN) was last updated on 6/15/2024 by MarketBeat.com Staff From Our PartnersExposed: 3 CENT Crypto to Explode June 24th?Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredTiny, One-Half Inch Pellet the Key to INFINITE Energy?It’s a tiny, $1 billion company that holds the key to this power. And yet, it’s the largest company of its ...Eagle Publishing | SponsoredTop 5 Tech Stocks to Buy for 2024The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...Daily Market Alerts | SponsoredTop 5 AI Stocks to Buy for 2024The electric vehicle boom is accelerating – and fast.Market Moving Trends | SponsoredHurry! Buy this stock before the Robinhood traders do!Robinhood traders have piled $78 billion into this market... Driving tiny tech stock gains of 3,000%, 8,942...Traders Agency | SponsoredAI's Next Magnificent SevenThe Original Magnificent Seven Produced 16,894% Average Returns Over 20 Years.The Oxford Club | SponsoredThe #1 Crypto That You Don’t Own… YetThere’s all kinds of “signals” to follow when investing in cryptos. But there’s one signal you should pay a...Crypto 101 Media | SponsoredThe Only Energy Play You Should Be Looking AtOpen AI’s Sam Altman recently helped this company raise $577 million in funding… What’s more is, It has alr...Wealthpin Pro | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sientra, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Sientra With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.